tiprankstipranks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market

Emmaus Life Sciences (EMMA) Income Statement

Compare
89 Followers

Emmaus Life Sciences Income Statement

Last quarter (Q3 2024), Emmaus Life Sciences's total revenue was $5.48M, an increase of 9.17% from the same quarter last year. In Q3, Emmaus Life Sciences's net income was $1.83M. See Emmaus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 29.60M$ 18.39M$ 20.61M$ 23.17M$ 22.75M
Gross Profit
$ 28.25M$ 15.80M$ 17.30M$ 20.92M$ 21.66M
Operating Expenses
$ 24.71M$ 22.39M$ 23.43M$ 20.95M$ 26.17M
Depreciation and Amortization
$ 32.00K$ 53.00K$ 59.00K$ 60.00K$ 73.00K
EBITDA
$ 3.57M$ -5.50M$ -12.76M$ 28.00K$ -26.98M
Operating Income
$ 3.54M$ -6.59M$ -6.13M$ -43.00K$ -4.51M
Other Income/Expenses
$ -7.33M$ -3.98M$ -9.79M$ 1.00M$ -50.17M
Pretax Income
$ -3.79M$ -10.63M$ -15.92M$ 719.00K$ -54.68M
Net Income
$ -3.73M$ -10.69M$ -15.95M$ 1.35M$ -54.84M
Per Share Metrics
Basic EPS
$ -0.07$ -0.22$ -0.32$ 0.03$ -1.30
Diluted EPS
$ -0.07$ -0.22$ -0.32$ 0.03$ -1.30
Weighted Average Shares Outstanding
53.11M 49.44M 49.25M 48.90M 42.26M
Weighted Average Shares Outstanding (Diluted)
53.11M 49.44M 49.25M 48.90M 42.26M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis